Subscribe
shutterstock_1682808808_tata_donets
Tata Donets / Shutterstock.com
10 February 2022BiotechnologyChiara Banas

UN International Day of Women and Girls in Science: a perspective

Friday, February 11, marks the United Nations International Day of Women and Girls in Science. The day focuses on the reality that science and gender equality are both vital for the achievement of internationally agreed development goals, including the 2030 Agenda for Sustainable Development.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
Women in STEM: Bridging the gender gap
21 May 2019   A plethora of studies have indicated that diversity drives innovation and economic performance, so why are the STEM fields, where innovation is the life-blood, so behind on gender diversity? WIPR investigates the reasons behind the failure to attract and retain women, and what needs to be done.
Big Pharma
Why mentorship matters
25 January 2022   Effective support and guidance can achieve greater diversity in life sciences, say general counsel from Bristol Myers Squibb, AstraZeneca, The Chemours Company and Eli Lilly.
Biotechnology
Promoting women in STEM
15 November 2022   What does it mean for women to be at the heart of our business? Janine Swarbrick and Sofie McPherson of HGF examine the gender balance in IP and what is being done to improve it.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

article
Women in STEM: Bridging the gender gap
21 May 2019   A plethora of studies have indicated that diversity drives innovation and economic performance, so why are the STEM fields, where innovation is the life-blood, so behind on gender diversity? WIPR investigates the reasons behind the failure to attract and retain women, and what needs to be done.
Big Pharma
Why mentorship matters
25 January 2022   Effective support and guidance can achieve greater diversity in life sciences, say general counsel from Bristol Myers Squibb, AstraZeneca, The Chemours Company and Eli Lilly.
Biotechnology
Promoting women in STEM
15 November 2022   What does it mean for women to be at the heart of our business? Janine Swarbrick and Sofie McPherson of HGF examine the gender balance in IP and what is being done to improve it.

More on this story

article
Women in STEM: Bridging the gender gap
21 May 2019   A plethora of studies have indicated that diversity drives innovation and economic performance, so why are the STEM fields, where innovation is the life-blood, so behind on gender diversity? WIPR investigates the reasons behind the failure to attract and retain women, and what needs to be done.
Big Pharma
Why mentorship matters
25 January 2022   Effective support and guidance can achieve greater diversity in life sciences, say general counsel from Bristol Myers Squibb, AstraZeneca, The Chemours Company and Eli Lilly.
Biotechnology
Promoting women in STEM
15 November 2022   What does it mean for women to be at the heart of our business? Janine Swarbrick and Sofie McPherson of HGF examine the gender balance in IP and what is being done to improve it.

More features

Sarepta wins $115M in patent dispute over muscular dystrophy drug
CREATES Act unfairly tips the scales to generics
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
Judge denies Intellia bid to throw out suit over $100m Regeneron pact
Trump’s return sparks calls for pro-patent agenda
Amgen faces pushback over bid to narrow patent scope